Skip to content
Contact
Keep up-to-date
with us
Tag: AI/ML
World Orphan Drug Congress Europe 2025 | Volv Global in Amsterdam
-
25/08/2025
Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI: Volv Global at the Rare Trials Summit 2025
-
25/08/2025
ATS 2025: 2 posters on the application of an AI model to detect Alpha-1 Antitrypsin Deficiency
-
17/04/2025
Conference Poster: Swiss Biotech Day 2025, 5th-6th May
-
05/04/2025
Press Release: Volv Global Expands Office Footprint to Power Next-Generation AI Innovation in Healthcare
-
05/03/2025
Where technology meets Human: Volv Global at the World Orphan Drug Congress USA 2025
-
23/02/2025
News Article: Volv Global Tracks Nearly Undetectable Diseases
-
30/01/2025
ATS 2024: Poster on Alpha-1 Antitrypsin Deficiency – Why millions remain undiagnosed
-
13/05/2024
White Paper: The Path to Rare Disease Clinical Trial Innovation
-
31/12/2022
How we help you
Clinical Development
Value and Access, HEOR
Medical Affairs
Commercial Excellence
inTrigue
inTrigue
What we do
Finding patients
Earlier detection
Predicting patient outcomes
Stratifying patient cohorts
Knowledge Hub
Insights
Case Studies
Events
News
Articles
Patient Resources
Meet Volv Global
Meet Volv Global
FAQ
How we help you
Clinical Development
Value and Access, HEOR
Medical Affairs
Commercial Excellence
inTrigue
What we do
Finding patients
Earlier detection
Predicting patient outcomes
Stratifying patient cohorts
Knowledge Hub
Insights
Case Studies
Events
News
Articles
Patient Resources
Meet Volv Global
